Added value of radiomics analysis in MRI invisible early-stage cervical cancers
- 1 May 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 95 (1133) , 20210986
Abstract
Objectives: To determine the diagnostic ability of cervical mucosa radiomics signature of sagittal T2WI and T1 contrast-enhanced (CE) imaging in detecting early-stage cervical cancers with negative MRI. Methods: Preoperative images of postoperative pathology confirmed early-stage cervical cancer patients and normal cervix patients admitted to our hospital between January 2013 and December 2020 were retrospectively reviewed. Patients with cancer signals on T2WI, T1CE and DWI were deleted. Regions of interests (ROIs) were delineated on cervical mucosa (from cervical canal to cervical dome) with 5 mm width on sagittal T2WI and T1CE. The maximum-relevance and minimumredundancy (mRMR) and least absolute shrinkage and selection operator (LASSO) methods were used for the calculation of radiomics signature scores. Diagnostic performance was assessed and compared between radiomics prediction models (model 1: T1CE; model 2: T2WI; model 3: model one combined with model 2). Differential diagnostic ability of radiomics signature in detecting lymphatic vascular space invasion (LVSI) was further explored. Results: Diagnostic performance of model three was higher than model 1 and model 2 both in primary (model 3 0.874, model 1 0.857, model 2 0.816) and validation (model 3 0.853, model 1 0.847, model 2 0.634) cohorts. Model 3 showed statistical diagnostic difference compared with model 2 (primary p = 0.008, validation p = 0.000). However, the diagnostic improvement ability of model 3 showed no statistical difference compared with model 1 (primary p = 0.351, validation p = 0.739). Diagnostic efficiency of model 3 in detecting LVSI was not apparent (AUC 0.64). Conclusions: Radiomics analysis of cervical mucosa combining T1CE and T2WI is promising for predicting MRI invisible early-stage cervical cancers, however further ability in detecting LVSI was not apparent. Advances in knowledge: Conventional MRI was originally defined as meaningless in very early-stage cervical cancers. However, whether MRI radiomics analysis of cervical mucosa can detecting tiny changes of invisible early stage cervical cancers has not been researched yet.Keywords
This publication has 30 references indexed in Scilit:
- Deciphering the Multifactorial Susceptibility of Mucosal Junction Cells to HPV Infection and Related CarcinogenesisViruses, 2017
- Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004–2013Cancer Medicine, 2017
- Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?International Journal of Cancer, 2016
- Comparison of optimised endovaginal vs external array coil T2-weighted and diffusion-weighted imaging techniques for detecting suspected early stage (IA/IB1) uterine cervical cancerEuropean Radiology, 2015
- Postoperative outcomes of MR-invisible stage IB1 cervical cancerAmerican Journal of Obstetrics and Gynecology, 2014
- Patients with cervical cancer: why did screening not prevent these cases?American Journal of Obstetrics and Gynecology, 2011
- Screening and adenocarcinoma of the cervixInternational Journal of Cancer, 2009
- Early Invasive Cervical Cancer: CT and MR Imaging in Preoperative Evaluation—ACRIN/GOG Comparative Study of Diagnostic Performance and Interobserver VariabilityRadiology, 2007
- Correlation between MRI and histopathologic findings in stage I cervical carcinomas: influence of stromal desmoplastic reactionInternational Journal of Gynecological Cancer, 2006
- The Relationship of Glands to Thick-Wall Blood Vessels as a Marker of Invasion in Endocervical AdenocarcinomaInternational Journal of Gynecological Pathology, 2005